Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a new revision label, Revision: v3.6.5, replacing the previous Revision: v3.6.4, signaling a small update to the page's versioning. This change is a metadata update and does not affect the study content or eligibility details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a new build of the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a small site update with no visible changes to the study details or eligibility criteria.SummaryDifference0.1%

- Check48 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, signaling an internal update to the site's backend or documentation rather than any change to the clinical trial details presented.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study record's contact/sponsor details were updated to separate the investigator's name from the institution, and additional help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), accompanied by a revision tag (v3.6.0).SummaryDifference2%

- Check69 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page content. The change updates the page metadata but does not alter the trial details.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.